Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02835937 · ClinicalTrials.gov registry record · NA
Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02835937: Completed NA study, sponsored by Mayo Clinic.
NCT02835937 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02835937, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Do ambulatory RBC transfusions improve home functional status?
Interventions
- OTHER No-Transfuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2017-11-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02835937
The ClinicalTrials.gov registry entry for NCT02835937 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No-Transfuse is the first listed.
NCT02835937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02835937 about?
NCT02835937 is a clinical study titled "Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status". Do ambulatory RBC transfusions improve home functional status?
What is the current status of trial NCT02835937?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-09-01. Estimated completion is 2017-11-10.
What interventions are being tested in trial NCT02835937?
The interventions under investigation include: No-Transfuse (OTHER).
Who is sponsoring clinical trial NCT02835937?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.